Work

Pooled Safety Summary for Patients Treated with the CD22-Directed Cytotoxin Moxetumomab Pasudotox-tdfk

Year: 2019

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.07.207

Authors: Robert Kreitman, Steven Coutre, Cynthia Elesinmogun, Nataliya Kuptsova-Clarkson, Xia Li, Ira Pastan, Douglas Gladstone

Institutions: National Institutes of Health, National Cancer Institute, Stanford Medicine, Stanford University, AstraZeneca (United States), Johns Hopkins University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970455894

FWCI:

Cites:

Cited by:

Related to: 10